Growth Capital For Life Sciences & Healthcare
Telegraph Hill Partners is a venture capital firm dedicated to helping life science, medical device and healthcare companies achieve their growth objectives. When you work with us, you get an experienced team that knows how to drive growth and profitability while maintaining the vision and integrity of the organization.
We seek to partner with innovative companies by providing capital and strategic guidance to help them grow.
Latest News & Announcements
Cellmark and Verogen Collaborate to Make the Next Generation of Forensic DNA Analysis Available to UK Police
San Diego, May 8, 2019—Cellmark Forensic Services and Verogen have signed a collaboration agreement to establish Cellmark as a United Kingdom (UK) center of excellence for forensic next generation sequencing (NGS), also known as massively parallel DNA sequencing (MPS). Verogen, the leading provider [...]
Medpricer Signs Deal with Texas Children’s Hospital for Purchased Services Sourcing
May 8th, 2019 – Guilford, CT/Walnut Creek, CA – Medpricer, the leading purchased services cost management solution for the health care industry, announced today that Texas Children’s Hospital chose its mSource software platform to centralize its purchased service sourcing efforts. Texas Children’s H [...]
Nimble Therapeutics Spins Out from Roche to Commercialize Novel Drug Discovery Technology with Financing from Telegraph Hill Partners
April 30, 2019 (Madison, WI): Nimble Therapeutics has begun operating as a standalone business after spinning out from F. Hoffmann La Roche (SIX: RO, ROG; OTCQX: RHHBY) to commercialize its proprietary chemical synthesis technology for drug development. The company also completed a Series A financin [...]